Parte Receptora definition

Parte Receptora es la parte que recibe Información Confidencial en virtud de este Contrato.
Sample 1Sample 2
Parte Receptora possui o significado atribuído na cláusula 34.1;
Sample 1

Examples of Parte Receptora in a sentence

  • La Parte Receptora protegerá y preservará la Información Confidencial como confidencial, con al menos el mismo cuidado con el que protege y preserva su propia información confidencial y de su titularidad (pero en ningún caso con un nivel de diligencia que sea menor a un grado razonable de cuidado) y no usará la Información Confidencial para propósito alguno excepto cuando sea necesario para llevar a cabo sus obligaciones bajo este Contrato.

  • Durante el Período, cualquiera de las Partes puede recibir (la "Parte Receptora") cierta información y materiales relacionados con los negocios, tecnología, clientes y productos de la otra Parte que xxxx confidenciales y de valor sustancial para la otra Parte (la "Parte Divulgadora").

  • La Parte Receptora no estará impedida de cumplir con la revelación ordenada por xx xxx aplicable si, donde fuera razonablemente viable y sin que implique el incumplimiento de cualquier requerimiento legal o regulatorio, diera previo aviso por escrito a la Parte Revelante del requerimiento de revelación.

  • La Parte Receptora no estará impedida de cumpIir con Ia reveIación ordenada por Ia Iey apIicabIe si, donde fuera razonabIemente viabIe y sin que impIique eI incumpIimiento de cuaIquier requerimiento IegaI o reguIatorio, diera previo aviso por escrito a Ia Parte ReveIante deI requerimiento de reveIación.

  • La "Información Confidencial" consiste en (a) cualquier información técnica o planes relativos a los Servicios, la Plataforma o cualquier software u otra tecnología de Taboola o de las Propiedades; (b) cualquier información financiera del Editor; (c) otra información revelada por la Parte Divulgadora a la Parte Receptora que se marque como confidencial o se debería asumir razonablemente que es confidencial en atención a las circunstancias; y (d) el contenido de este Contrato.

  • La Parte Receptora podrá revelar la Información Confidencial, si así le fuera exigido por la legislación aplicable o por cualquier resolución judicial o normativa administrativa, o por cualquier autoridad administrativa u otra autoridad reguladora.

  • Si la Parte Receptora viniera obligada por ley o por cualquier normativa o resolución administrativa o judicial a revelar dicha Información Confidencial, la Parte Receptora únicamente revelará aquella parte de dicha Información Confidencial que la Parte Receptora, en opinión de su asesor jurídico, viniera legalmente obligada a facilitar, y realizará esfuerzos razonables a efectos de mantener la confidencialidad del resto de la Información Confidencial de la Parte Reveladora.

  • En caso de que la Parte Receptora xx xxx obligada legalmente a divulgar Información Confidencial de la Parte Reveladora, la Parte Receptora lo notificará por escrito lo antes posible a la Parte Reveladora para que la Parte Reveladora pueda solicitar una orden de protección u otro recurso apropiado o eximir del cumplimiento de las disposiciones del presente Acuerdo.

  • En caso de que no se obtenga una orden de protección u otro recurso, o la Parte Reveladora exima del cumplimiento de las disposiciones del presente Acuerdo, la Parte Receptora proporcionará únicamente la Información confidencial que se requiera legalmente y ejercerá esfuerzos razonables para obtener una garantía fiable de que la Información Confidencial divulgada xx xxxxx de forma confidencial.

  • La Parte Receptora no estará impedida de cumplir con la revelación ordenada por xx xxx aplicable si, donde fuera razonablemente viable y sin que implique el incumplimiento de cualquier requerimiento legal o regulatorio, diera previo aviso por escrito a la Parte Reveladora del requerimiento de revelación.

Related to Parte Receptora

  • Receptor means enclosed spaces, conduits, protected groundwater sources, drinking and non-drinking water wells, surface water bodies, and public water systems which when impacted by chemicals of concern may result in exposure to humans and aquatic life, explosive conditions or other adverse effects on health, safety and the environment as specified in these rules.

  • Image receptor means any device, such as a fluorescent screen or radiographic film, which transforms incident X-ray photons either into a visible image or into another form which can be made into a visible image by further transformations.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Source-image receptor distance means the distance from the source to the center of the input surface of the image receptor.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Preceptor means an individual who provides, directs, or verifies training and experience required for an individual to become an authorized user, an authorized medical physicist, an authorized nuclear pharmacist, or a radiation safety officer.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • DNA profile means a letter or number code which represents a set of identification characteristics of the non-coding part of an analysed human DNA sample, i.e. the particular molecular structure at the various DNA locations (loci);

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Diagnostic mammography means a method of screening that

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Librarian means an educator who provides full-time library ser- vices and holds the relevant certificate from SBEC.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Attack directed against any civilian population means a course of conduct involving the multiple commission of acts referred to in paragraph 1 against any civilian population, pursuant to or in furtherance of a State or organizational policy to commit such attack;

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Pharmacist preceptor or “preceptor” means a pharmacist licensed to practice pharmacy whose license is current and in good standing. Preceptors shall meet the conditions and requirements of rule 657—4.9(155A). No pharmacist shall serve as a preceptor while the pharmacist’s license to practice pharmacy is the subject of disciplinary sanction by a pharmacist licensing authority.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Opioid antidote means any drug, regardless of dosage amount or method of administration, which has been approved by the United States Food and Drug Administration (FDA) for the treatment of an opioid overdose. “Opioid antidote” includes, but is not limited to, naloxone hydrochloride, in any dosage amount, which is administered through nasal spray or any other FDA-approved means or methods.

  • Opioid antagonist means a drug that binds to opioid

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Patent Cooperation Treaty means the Patent Cooperation Treaty done at Washington on June 19, 1970;